Latest Videos
Video
Ann Lacasce, MD, MMSc discusses treatment in early stage high-risk cHL patients
Ann Lacasce MD, MMSc, of Dana-Farber Cancer Institute presented findings at #ASH24 suggesting treatment with brentuximab vedotin and nivolumab can reduce toxicities and may decrease the need for radiation in early stage high-risk cHL patients.
Video
Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients
Jacqueline Garcia, MD, of Dana-Farber Cancer Institute presented at #ASH24 data suggesting oral maintenance therapy with venetoclax and decitabine/cedazuridine after HCT is safe, feasible, and may reduce relapse rates in high-risk AML/MDS patients.
Video
Katie Maurer, MD, PhD discusses HSCT treatment
Katie Maurer, MD, PhD, from Dana-Farber Cancer Institute, shared #ASH24 findings suggesting that diverse bone marrow cell composition may predict treatment response in the content of AML patients undergoing HSCT.
Video
Jennifer Brown, MD, PhD reviews Phase 2 Amplify trial
Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.
Video
Colleen Kelly, MD discusses findings on RISE
At #ASH24, researcher, Colleen Kelly MD, presented findings on RISE, a Dana-Farber led program aiding low-income families of kids with cancer. Results show promise.
Video
Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial
Findings from a Phase 3 acute myeloid leukemia trial presented at #ASH24 show CPX-351 improves survival for AML-MR patients. Lead authors Shai Shimony, MD, MPH, and H. Moses Murdoch, MD, of Dana-Farber Cancer Institute, explain more in this video.
Video
Daniel DeAngelo, MD, PhD on a novel systemic mastocytosis (SM) drug
Daniel DeAngelo, MD, PhD, of Dana-Farber Cancer Institute, presented findings at #ASH24 on two abstracts regarding a novel systemic mastocytosis (SM) drug with high response rates & a tool that identifies SM subtypes with 90% accuracy.
Video
Matthew Davids, MD, MMSc discusses time-limited AVO triplet therapy
In a new study published in the Journal of Clinical Oncology and presented at #ASH24, Matthew Davids, MD, MMSC, of Dana-Farber Cancer Institute, shared promising findings: a time-limited AVO triplet therapy offers durable remission for high-risk CLL patients.
Latest Documents
Document
Case Spotlight: Advanced Polyp Resection Using DiLumen® in the Distal Sigmoid Colon
This new clinical case report showcases an innovative use of the DiLumen® Endoluminal Interventional Platform (EIP) by Dr. Sandro Sferrazza at Santa Chiara Hospital, Italy.
Document
Aortic Valve Replacement: Ross Procedure
Learn more on the Aortic Valve Replacement: Ross Procedure.
Latest Articles
News
UCSF’s Anbukkarasi Muniyandi Accepted into Prestigious Emerging Vision Scientist Program
UCSF vision researcher Anbukkarasi Muniyandi, PhD, has been selected as an “Emerging Vision Scientist (EVS)” by the National Alliance for Eye and Vision Research (NAEVR)
News
How Neurons Build a 3-D Vascular Structure to Keep the Retina Healthy
Understanding how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for conditions like diabetic retinopathy and stroke.
News
Joint Preservation Patients May Be Able to Avoid Joint Replacement
Joint preservation surgery is constantly evolving and in the appropriately indicated patient has reliable outcomes for pain and function.
News
A Shining Light for Cataract Patients
A breakthrough in cataract technology is bringing renewed hope to patients seeking improved vision. UCSF cataract surgeons are now using the innovative Light Adjustable Lens™ (LAL) in a growing number of patients who undergo cataract surgery at UCSF Health.
Latest Courses
Course
Hyperthyroidism and Thyroid Eye Disease Updates
In this CME, Esra Karslioglu French, MD, and S. Tonya Stefko, MD, discuss how to implement Thyroid Eye Disease outcomes by utilizing correct diagnosis and treatment strategies, recognizing the treatment indications and side effects of ...
Course
In this CME, Manish Gupta, MD, discusses factors in kidney allocation and describes the benefits of living kidney donation.
Course
2025 Cedars-Sinai International Endoscopy Symposium
Thursday, January 30, 2025, 7:30 AM - Saturday, February 1, 2025, 5:45 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
Course
The 16th Annual Symposium on Neurovascular Disease
Saturday, January 25, 2025, 7:30 AM - 5:10 PM PST, Other, Santa Monica, CA
